A publicly funded randomized trial found that a single 25 mg dose of psilocybin, given alongside structured psychological support, reduced depression symptoms significantly more than placebo in adults with treatment-resistant depression.

What the Trial Found

In the trial of 60 adults with treatment-resistant depression, participants who received psilocybin plus psychological support showed a greater reduction in depression scores through six weeks than those who received placebo plus the same support. About half of the psilocybin group showed a meaningful treatment response, compared with a small fraction of the placebo group, and roughly two in five reached remission, compared with almost none on placebo.

Why It Matters

Treatment-resistant depression, where standard antidepressants and therapy have not produced enough improvement, can leave people feeling as though they have run out of options. This trial adds to a growing body of research suggesting that psilocybin, administered under supervision and combined with psychological support, may help some people in this group when other treatments have not worked, and its public funding reflects growing mainstream interest in testing these approaches rigorously.

What This Research Does Not Prove

This was a six-week trial in a relatively small group of 60 people, so it does not establish long-term safety or effectiveness, and not everyone responded. Psilocybin was given in a controlled clinical setting with trained support, which is different from unsupervised or recreational use. The treatment is not currently approved for general use outside of clinical trials in most places.

When to Seek Help

If standard antidepressants and therapy have not sufficiently improved your depression after adequate trials, it may be worth discussing treatment-resistant depression and its evolving treatment options with a psychiatrist.

How to Talk to Your Doctor About This

It can help to bring a clear history of which antidepressants and therapies you have tried, for how long, and at what doses, so your provider can assess whether your depression meets criteria for treatment resistance and what next steps, including clinical trial options, might be appropriate.

Which Professional to See

A psychiatrist experienced in treatment-resistant depression is best positioned to evaluate your history and discuss emerging options, including whether you might be eligible for a clinical trial.

Questions to Ask

Consider asking: Does my depression meet the criteria for treatment-resistant depression? Are there clinical trials I could be eligible for? What are the risks and requirements of supervised psilocybin treatment where it is being studied?

Bottom Line

This trial adds solid, publicly funded evidence that supervised psilocybin treatment can help some people with treatment-resistant depression in the short term, though it remains an experimental, closely supervised treatment rather than a standard option.

Related Topics

Related reading: Major Depressive Disorder